Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 7, Issue 2, 2001, Pages 208-215

  Rabe, C ^a   Pilz, T ^a   Klostermann, C ^a   Berna, M ^a   Schild, H H ^a   Sauerbruch, T ^a   Caselmann, W H ^a  

^a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALPHA FETOPROTEIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; IODINATED POPPYSEED OIL; PLACEBO; TAMOXIFEN;

ADULT; ADVANCED CANCER; AGED; ALCOHOL ABUSE; ARTICLE; ASCITES; CANCER INCIDENCE; CANCER INFILTRATION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GERMANY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; INJECTION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN THROMBOSIS; REHABILITATION MEDICINE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIRUS HEPATITIS;

EID: 0035037858     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i2.208     Document Type: Article

References (64)

1. The incidence of hepatocellular carcinoma in New Zealand
2. Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand
3. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
4. Hepatitis B virus. The major etiology of hepatocellular carcinoma
5. Interaction of Hepatitis B virus with cellular processes in liver carcinogenesis
6. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma
7. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
8. Hepatitis C virus core protein represses p21WAF1/ Cip1/ Sid1 promoter activity
9. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype
10. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma
11. Transcriptional repression of p53 promoter by hepatitis C virus core protein
12. A comparison of hepatocellular carcinoma associated with HBV or HCV infection
13. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection
14. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group
15. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan
16. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1 643 patients using statistical bias correction with proportional hazard analysis
17. Hepatocellular carcinoma in Sweden: Its association with viral hepatitis, especially with hepatitis C viral genotypes
18. Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis
19. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China
20. High prevalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan
21. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; A study in Greece using third-generation assays
22. Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan
23. Carcinogenesis of primary liver malignancies
24. Incidence and risk factors for hepatocellular carcinoma in 967 patients with cirrhosis
25. Most of the patients with cirrhosis in Japan die from hepatocellular carcinoma
26. Liver cancer among employees in Denmark
27. Chronic liver diseases for the risk of hepatocellular carcinoma: A case- control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases
28. A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study
29. Survival and causes of death in hemochromatosis. Observations in 163 patients
30. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation
31. Results of hepatic resection and transplantation for fibrolamellar carcinoma
32. International registry of liver tumors in liver transplantation. A registry update on hepatocellular carcinoma (HCC)
33. Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16-year population-based study
34. Improved survival with screening for hepatocellular carcinoma
35. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis
36. Natural history of untreated primary hepatocellular carcinoma: A retrospective study of 157 patients
37. Prognosis of hepatocellular carcinoma in relation to treatment: A multivariate analysis of 178 patients from a single European institution
38. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study
39. Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area
40. Hepatocellular carcinoma in Germany. Epidemiology, etiology, clinical aspects and prognosis in 100 consecutive patients of a university clinic
41. Hepatocellular carcinoma in Belgium: Clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients
42. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C
43. Trends in mortality from primary liver cancer in Europe
44. Risk factors for the rising rates of primary liver cancer in the united states
45. Primary hepatocellular carcinoma in Australia, 1978 - 1997: Increasing incidence and mortality
46. Primary hepatic cancer and liver cirrhosis. Autopsy study covering fifty years
47. The epidemiology of primary liver cancer in a West German population: The Saarland
48. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with child - Turcotte class B and C cirrhosis
49. Attributable risks for hepatocellular carcinoma in northern Italy
50. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years
51. Glucose resistance contributes to diabetes mellitus in cirrhosis
52. Hepatogenic diabetes: Pathophysiology, therapeutic options and prognosis
53. The preS2/ S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator
54. A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA
55. Trans-activation of cellular genes by hepatitis B virus proteins: A possible mechanism of hepatocarcinogenesis
56. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - A single-center analysis including 132 patients
57. Hepatocellular carcinoma in Austria: Aetiological and clinical characteristics at presentation
58. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study
59. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma
60. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients
61. Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 year survival in 112 patients
62. Percutaneous interstitial thermotherapy of malignant liver tumors
63. Radiofrequency ablation in the treatment of hepatocellular carcinoma - A clinical viewpoint